​

OptimizeRx (OPRX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

OPRX Stock Forecast

OptimizeRx (OPRX) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $20.00, with a high of $23.00 and a low of $17.00. This represents a 202.11% increase from the last price of $6.62.

- $5 $10 $15 $20 $25 High: $23 Avg: $20 Low: $17 Last Closed Price: $6.62

OPRX Stock Rating

OptimizeRx stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (73.33%), 4 Hold (26.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 15 4 11 0 Strong Sell Sell Hold Buy Strong Buy

OPRX Price Target Upside V Benchmarks

TypeNameUpside
StockOptimizeRx202.11%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 47.64%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$17.00$17.00$20.00
Last Closing Price$6.62$6.62$6.62
Upside/Downside156.80%156.80%202.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26151--7
Feb, 26151--7
Jan, 26151--7
Dec, 25151--7
Nov, 25151--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 06, 2026David GrossmanStifel Nicolaus$17.00$6.80150.00%156.80%
Oct 10, 2025UBS$23.00$18.2925.75%247.43%
Apr 04, 2024Constantine DavidesJMP Securities$15.00$11.1734.29%126.59%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 10, 2025CitigroupOutperformOutperformhold
Aug 08, 2025Roth CapitalBuyBuyhold
May 13, 2025B. RileyBuyBuyhold
May 13, 2025Roth CapitalBuyBuyhold
May 13, 2025CitigroupOutperformOutperformhold
Dec 24, 2024B. RileyBuyBuyhold
Dec 24, 2024Lake StreetBuyBuyhold
Nov 14, 2024Lake StreetBuyBuyhold
Aug 12, 2024JMP SecuritiesMarket OutperformMarket Outperformhold
Jun 21, 2024Stifel NicolausMarket OutperformMarket Outperformhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$0.02$-0.64$-1.03$-1.10$0.28-
Avg Forecast$0.43$0.35$0.37$0.31$0.34$0.48
High Forecast$0.46$0.37$0.45$0.48$0.53$0.66
Low Forecast$0.38$0.33$0.30$0.26$0.19$0.30
Surprise %-95.35%-282.86%-378.38%-454.84%-17.65%-

Revenue Forecast

$55M $67M $79M $91M $103M $115M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$61.29M$62.45M$71.52M$92.13M$109.43M-
Avg Forecast$61.14M$64.57M$71.08M$90.17M$99.65M$108.91M
High Forecast$64.71M$67.07M$71.31M$90.90M$104.08M$114.68M
Low Forecast$55.86M$61.85M$70.84M$89.04M$94.65M$103.20M
Surprise %0.25%-3.28%0.63%2.17%9.81%-

Net Income Forecast

$-25M $-17M $-9M $-1M $7M $15M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$378.08K$-11.44M$-17.57M$-20.11M$5.13M-
Avg Forecast$379.29K$-8.47M$-17.57M$6.31M$6.19M$8.22M
High Forecast$710.10K$-6.48M$-13.48M$8.19M$9.12M$11.22M
Low Forecast$48.48K$-10.45M$-21.65M$4.43M$3.26M$5.22M
Surprise %-0.32%35.07%0.00%-418.68%-17.09%-

OPRX Forecast FAQ

Is OptimizeRx stock a buy?

OptimizeRx stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that OptimizeRx is a favorable investment for most analysts.

What is OptimizeRx's price target?

OptimizeRx's price target, set by 15 Wall Street analysts, averages $20 over the next 12 months. The price target range spans from $17 at the low end to $23 at the high end, suggesting a potential 202.11% change from the previous closing price of $6.62.

How does OptimizeRx stock forecast compare to its benchmarks?

OptimizeRx's stock forecast shows a 202.11% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare information services stocks industry (47.64%).

What is the breakdown of analyst ratings for OptimizeRx over the past three months?

  • March 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is OptimizeRx’s EPS forecast?

OptimizeRx's average annual EPS forecast for its fiscal year ending in December 2026 is $0.48, marking a 71.43% increase from the reported $0.28 in 2025..

What is OptimizeRx’s revenue forecast?

OptimizeRx's average annual revenue forecast for its fiscal year ending in December 2026 is $108.91M, reflecting a -0.48% decrease from the reported $109.43M in 2025.

What is OptimizeRx’s net income forecast?

OptimizeRx's net income forecast for the fiscal year ending in December 2026 stands at $8.22M, representing an 60.17% increase from the reported $5.13M in 2025.